Effect of conjugated estrogen versus conjugated estrogen associated with medroxyprogesterone acetate in postmenopausal women on internal carotid artery pulsatility index: A randomized pilot study

Journal of Obstetrics and Gynaecology Research

Volumn 37, Issue 7, 2011, Pages 815-818

  Wender, Maria C O ^a,b,c   Vigo, Francieli ^b   Oliveira, Patricia P ^b   Bittellbrun, Fernando ^b   Furtado, Alvaro P A ^b   Schvartzman, Luiza ^a   Capp, Edison ^a,b,c,d   De Freitas, Fernando Monteiro ^b,c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b Clinics Hospital of Porto Alegre   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Hospital of Porto Alegre   (Brazil)

Author keywords

Carotid artery; Doppler ultrasound; Estrogen; medroxyprogesterone acetate; Menopause

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY FLOW; CHOLESTEROL BLOOD LEVEL; COLOR ULTRASOUND FLOWMETRY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROSPECTIVE STUDY; PULSATILITY INDEX; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL;

CAROTID ARTERY DISEASES; CAROTID ARTERY, INTERNAL; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; PILOT PROJECTS; POSTMENOPAUSE; PULSATILE FLOW; SINGLE-BLIND METHOD;

EID: 80052703512     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01441.x     Document Type: Article

References (18)

1. Wildman RP, Colvin AB, Powell LH et al. Associations of endogenous sex hormones with the vasculature in meno-pausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008; 15: 414-421. (Pubitemid 351656744)
2. Barrett-Connor E, Grady D. Hormone replacement therapy heart disease, and other considerations. Annu Rev Public Health 1998; 19: 55-72. (Pubitemid 28279924)
3. Grodstein F, Stampfer MJ, Manson JE et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453-461. (Pubitemid 26269944)
4. Hemelaar M, van der Mooren MJ, van Baal WM, Schalkwijk CG, Kenemans P, Stehouwer CD. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy post-menopausal women. Menopause 2005; 12: 526-535. (Pubitemid 41362076)
5. Calleja-Agius J, Brincat MP. Hormone replacement therapy post Women's Health Initiative study: where do we stand. Curr Opin Obstet Gynecol 2008; 20: 513-518.
6. Rosano GM, Vitale C, Fini M. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system. Ann NY Acad Sci 2006; 1092: 341-348. (Pubitemid 47092351)
7. Brosnan JF, Sheppard BL, Norris LA. Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration. Thromb Haemost 2007; 97: 558-565. (Pubitemid 46592933)
8. Jackson S, Vyas S. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index. Br J Obstet Gynaecol 1998; 105: 408-412. (Pubitemid 28237867)
9. Penotti M, Farina M, Castiglioni E et al. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study. Am J Obstet Gynecol 1996; 175: 606-611.
10. Sumino H, Ichikawa S, Kasama S et al. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmeno-pausal women. Atherosclerosis 2006; 189: 436-442. (Pubitemid 44634490)
11. Yeboah J, Reboussin DM, Waters D, Kowalchuk G, Her-rington DM. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease. Am Heart J 2007; 153: 439-444. (Pubitemid 46328751)
12. Bui MN, Arai AE, Hathaway L, Waclawiw MA, Csako G, Cannon RO III. Effect of hormone replacement therapy on carotid arterial compliance in healthy postmenopausal women. Am J Cardiol 2002; 90: 82-85. (Pubitemid 34671214)
13. Kallikazaros I, Tsioufis C, Zambaras P, Stefanadis C, Toutou-zas P. Conjugated estrogen administration improves common carotid artery elastic properties in normotensive postmenopausal women. Clin Cardiol 2002; 25: 167-172. (Pubitemid 34263957)
14. Luckas MJ, Gleeve T, Biljan MM et al. The effect of progestagens on the carotid artery pulsatility index in post-menopausal women on oestrogen replacement therapy. Eur J Obstet Gynecol Reprod Biol 1998; 76: 221-224. (Pubitemid 28031917)
15. De Leo V, la Marca A, Orlandi R, Crippa D, Setacci C, Petra-glia F. Effects of estradiol alone or in combination with cypro-terone acetate on carotid artery pulsatility index in postmenopausal women. Maturitas 2003; 46: 219-224. (Pubitemid 37338410)
16. Lazar F Jr, Costa-Paiva L, Pinto-Neto AM, Martinez EZ. Carotid and uterine vascular resistance in short-term hormone replacement therapy postmenopausal users. Maturitas 2004; 48: 472-478.
17. Scuteri A, Lakatta EG, Bos AJ, Fleg JL. Effect of estrogen and progestin replacement on arterial stiffness indices in post-menopausal women. Aging (Milano) 2001; 13: 122-130. (Pubitemid 32496333)
18. Fernandes CE, Pompei LM, Machado RB, Ferreira JA, Melo NR, Peixoto S. Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow. Maturitas 2008; 59: 249-258.